Grant: Discovery Grants Program - Individual
University of Toronto
$81,700.00
Systematic stem cell bioprocess engineering
EF 2012-13
Résumé
Cell-based therapeutics are motivated by the observation that many cell transplantation procedures yield significant benefits to patients. Unfortunately however, the cells and/or tissues needed to treat the numbers of patients that could benefit from cell transplantation significantly outstrip availability from donors. Stem cells have generated much excitement as a potential source of cells for drug development and cell-based therapeutics because of their ability to self-renew (divide while maintaining stem cell properties) and differentiate into functional cells (such as blood or heart cells). The proposed studies will continue our efforts to develop a mechanism-based technological platform for the generation of therapeutically relevant cells from pluripotent stem cells.
1) Signaling network dynamics and stable pluripotent cell states - In this project we will investigate how different pluripotent stem cells (embryonic stem cells and epiblast stem cells) with an apparently similar core transcriptional network can be stabilized by two completely different signaling networks.
2) Bioprocesses for generating, capturing and expanding pluripotent stem cell-derived blood progenitors. This project will investigate the use of engineered peptide transduction domain-transcription factor fusion proteins and episomal transgene expression strategies to induce and propagate blood stem cells from phenotypically defined pluripotent stem cell-derived cells.
These studies use novel bioengineering strategies uncover fundamental mechanisms regulating the stabilization of pluripotent stem cell populations (Project 1), and the differentiation of these pluripotent cells into functional blood stem cells (Project 2). The highly qualified personnel emerging from the proposed research program should have with the tools and expertise to lead next generation Canadian biotechnology activities.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
217024-2009
Name nom
Zandstra, Peter
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
81700
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
4
Nb partie
5
Application title
Systematic stem cell bioprocess engineering
Keyword
NSERC
Application summary
Cell-based therapeutics are motivated by the observation that many cell transplantation procedures yield significant benefits to patients. Unfortunately however, the cells and/or tissues needed to treat the numbers of patients that could benefit from cell transplantation significantly outstrip availability from donors. Stem cells have generated much excitement as a potential source of cells for drug development and cell-based therapeutics because of their ability to self-renew (divide while maintaining stem cell properties) and differentiate into functional cells (such as blood or heart cells). The proposed studies will continue our efforts to develop a mechanism-based technological platform for the generation of therapeutically relevant cells from pluripotent stem cells.
1) Signaling network dynamics and stable pluripotent cell states - In this project we will investigate how different pluripotent stem cells (embryonic stem cells and epiblast stem cells) with an apparently similar core transcriptional network can be stabilized by two completely different signaling networks.
2) Bioprocesses for generating, capturing and expanding pluripotent stem cell-derived blood progenitors. This project will investigate the use of engineered peptide transduction domain-transcription factor fusion proteins and episomal transgene expression strategies to induce and propagate blood stem cells from phenotypically defined pluripotent stem cell-derived cells.
These studies use novel bioengineering strategies uncover fundamental mechanisms regulating the stabilization of pluripotent stem cell populations (Project 1), and the differentiation of these pluripotent cells into functional blood stem cells (Project 2). The highly qualified personnel emerging from the proposed research program should have with the tools and expertise to lead next generation Canadian biotechnology activities.